AbbVie Says AndroGel Suit Should Be Moved To Georgia

By Matt Bernardini · November 26, 2019, 7:06 PM EST

AndroGel maker AbbVie has told a Philadelphia federal judge that an antitrust suit against the company in Pennsylvania should be consolidated with a similar suit in Georgia even though only one...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Response

Case Information

Case Title

KING DRUG COMPANY OF FLORENCE, INC. et al v. ABBOTT LABORATORIES et al

Case Number

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 07, 2019

Recent Articles By Matt

October 18, 2019
Ill. City Ran To Court In Discovery Row, Express Scripts Says
October 15, 2019
AbbVie Says Humira's Many Patents Is No Antitrust Violation
October 09, 2019
Fresenius To Pay $5M To Resolve Mass. Medicare Fraud
October 08, 2019
Calif. Becomes 1st State To Target 'Pay-For-Delay' Drug Deals
September 26, 2019
Gov't Backs SmileDirect In Ga. Dental Board Members' Appeal
September 26, 2019
Certification Board Escapes Doctors' Antitrust Suit
September 18, 2019
FCC Links Lifeline, Medicaid Program Enrollment
September 08, 2019
Congress Pressed To Renew Funding For Rape Kit Testing
August 30, 2019
FCC Trying To Mitigate Mexican Spectrum Interference
August 26, 2019
FTC Fights E-Prescription Co. Bid To Nix Monopoly Case